Medicenna Therapeutics Inc. — Form D
Medicenna Therapeutics Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-21. The offering totals $798K, of which $798K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-04-21
- Form: D
- Accession: 0001672726-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $798K
- Amount sold: $798K
- Investors: 1
- Date of first sale: 2016-04-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-261759
Issuer
- Name: Medicenna Therapeutics Inc.
- CIK: 0001672726
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2011
- Address: 439 HELMCKEN STREET, VANCOUVER, A1, V6B 2E6
- Phone: 604-671-6673
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Rosemina Merchant | Director | Toronto, A6 |
| Rosemina Merchant | Executive Officer | Toronto, A6 |
| Fahar Merchant | Director | Toronto, A6 |
| Fahar Merchant | Executive Officer | Toronto, A6 |
Other filings by this issuer (1)
More